论文部分内容阅读
国家药品监督管理局 2 0 0 2年 11月 2 8日以国药监安 [2 0 0 2 ] 42 5号发出《关于公布第四批国家非处方药药品目录 (一 )的通知》 ,《通知》称 ,经国家药品监督管理局审定 ,现公布第四批国家非处方药药品目录 (一 ) (下称《目录》)品种。此次公布的《目录》 ,共计 30 3个药品制剂。其中 :化学药品制剂 10 7个 (甲类非处方药 59个 ,乙类非处方药 4 8个 ) ,中成药制剂 196个 (甲类非处方药 14 2个 ,乙类非处方药 54个 )。《目录》公布后 ,请按照《关于做好 2 0 0 2年非处方药管理工作的通知》做好相关工作
On November 28, 2002, State Pharmaceutical Regulatory Commission [2 0 0 2] 42 5 issued the Notice on Disseminating the Fourth Batch of National OTC Pharmaceuticals (1), the Circular of the State Drug Administration on November 28, Said that after the approval of the State Drug Administration, is now the fourth batch of national non-prescription drugs directory (a) (hereinafter referred to as “directory”) varieties. The release of the “directory”, a total of 30 3 pharmaceutical preparations. Of these, 107 were in the form of chemical preparations (59 for Category A and 48 for Category B) and 196 for proprietary Chinese medicines (14 2 for over-the-counter A and 54 for non-prescription B). After the “Catalog” is announced, please follow the “Notice on Doing a Good Job of Non-prescription Drugs in 2002”